Ordering Recommendation

FDA-approved test for routine cervical cancer screening in individuals 25 years and older with a cervix.

New York DOH Approval Status

This test is not New York state approved. Alternative testing that is New York approved is available. See Ordering Recommendations.

Specimen Required

Patient Preparation

Cervical or endocervical specimen with SurePath collection kit. Cervical or endocervical specimen with brush or spatula from ThinPrep collection kit (ARUP supply #41785 ThinPrep (Vial and Broom) or #51369 ThinPrep (Vial, Brush and Spatula)) available online through eSupply using ARUP Connect™ or contact ARUP Client Services at 800-522-2787.

Specimen Preparation

Place collection device in corresponding SurePath or ThinPrep media vial.

Storage/Transport Temperature


Unacceptable Conditions

Bloody or dark brown specimens. Specimens in any media other than indicated above.


SurePath - Ambient: 1 month; Refrigerated: 6 months; Frozen: Unacceptable

ThinPrep - Ambient: 6 months; Refrigerated: 6 months; Frozen: Unacceptable


Qualitative Polymerase Chain Reaction (PCR)




1-5 days
If reflexed, add 1-7 days

Reference Interval


Interpretive Data

This test amplifies DNA of HPV16, HPV18 and 12 other high-risk HPV types (31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68) associated with cervical cancer and its precursor lesions. Sensitivity may be affected by specimen collection methods, stage of infection, and the presence of interfering substances. Results should be interpreted in conjunction with other available laboratory and clinical data. A negative high-risk HPV result does not exclude the presence of other high-risk HPV types, the possibility of future cytologic abnormalities, underlying CIN2-3, or cancer.

HPV testing should not be used for screening or management of atypical squamous cells of undetermined significance (ASCUS) in women under age 21.

Compliance Category

Depends on Specimen/Source/Method


For cervical sources, a negative high-risk HPV result does not exclude the possibility of future cytologic abnormalities, underlying CIN2-3, or cancer.

Hotline History


CPT Codes

87624; if reflexed add 88142; if reviewed by pathologist add 88141


Component Test Code* Component Chart Name LOINC
0060752 HPV Source 31208-2
2011935 HPV Genotype 16 by PCR 77399-4
3016637 HPV Genotype 18 by PCR 77400-0
3016638 HPV Media
3016759 HPV Other High Risk by PCR Primary Scrn 82675-0
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.


  • HPV 16 18 HPV High Risk
  • HPV HR with Cytology
  • HPV Primary Screening
  • HPV SurePath
  • HPV ThinPrep
  • HPV Typing
  • Human papilloma virus
HPV Primary Screen by PCR With Reflex to Cytology